ABSTRACT

The World Health Organization proclaimed the coronavirus pandemic of 2019 in March 2020. As there is currently no cure for the illness, immunizations and following COVID-appropriate behavior guidelines have emerged as the main tactics being used to contain the epidemic. To guarantee the best possible health for the general public, it is imperative to evaluate each vaccine's safety profile, as many have been approved after successful clinical trials. This study aimed to review the adverse drug reactions (ADRs) related to the Covishield vaccine, with an emphasis on the incidence of adverse effects in vaccine recipients. The review report was conducted at a tertiary care center to evaluate the adverse events following Covishield vaccination. Keywords: Coronavirus 2019, Adverse drug reactions, Post marketing Surveillance, Thrombosis with Thrombocytopenia Syndrome, Vaccination
Publication date: 01/10/2025

https://ijbpas.com/pdf/2025/October/MS_IJBPAS_2025_9529.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2025/14.10.9529